Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease

8 Nov 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Complement system in diseases
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30415998
DOI: 10.1016/j.neuron.2018.10.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s DiseasePMID 30415998Read ↗

Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic eventsSemantic proximity Read ↗

Complement C3aR deletion does not attenuate neurodegeneration in a tauopathy model or alter acute inflammation-induced gene expression changes in the brainSemantic proximity Read ↗

Complement-mediated synapse loss in Alzheimer’s disease: mechanisms and involvement of risk factorsSemantic proximity Read ↗

Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.Semantic proximity Read ↗

Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer’s diseaseSemantic proximity Read ↗

Complement-Mediated Events in Alzheimer’s Disease: Mechanisms and Potential Therapeutic TargetsSemantic proximity Read ↗

Yin and Yang: complement activation and regulation in Alzheimer’s diseaseSemantic proximity Read ↗

Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's diseaseSemantic proximity Read ↗

Complement therapeutics in neurodegenerative diseasesSemantic proximity Read ↗

The good, the bad, and the opportunities of the complement system in neurodegenerative diseaseSemantic proximity Read ↗

Complement in the pathogenesis of Alzheimer’s diseaseSemantic proximity Read ↗

Roles of the Complement System in Human Neurodegenerative DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.